Derma Sciences increases sales, but dips into red
Derma Sciences Inc. (OTC:DSCI) posted losses of $502,552, or 8 cents per diluted share, on sales of $15.1 million during the three months ended Sept. 30. That compares with profits of $139,603, or 3 cents per share, on sales of $12.9 million during the same period last year.
Read more
SANUWAVE sales double, but losses remain
SANUWAVE Health Inc. (OTC:SNWV) posted a loss of $2.7 million, or 21 cents per share, on sales of $278,212 during the three months ended Sept. 30. That compares with a loss of $2.7 million, or 24 cents per diluted share, on sales of $134,771 during the same period last year.
Read more
Misonix boosts sales, but losses follow
Misonix Inc. (NSDQ:MSON) posted losses of $1.0 million, or 15 cents per diluted share, on sales of $3.3 million during the three months ended Sept. 30. That compares with losses of $895,112, or 13 cents per diluted share, on sales of $2.6 million during the same period last year.
Read more
